Surender Rajasekaran

Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children*

Surender Rajasekaran, Katherine Kruse, Karen Kovey et al. · Pediatric Critical Care Medicine · 2014 · 191 citations · Full text

Platelet-Activating Factor Receptor and Innate Immunity: Uptake of Gram-Positive Bacterial Cell Wall into Host Cells and Cell-Specific Pathophysiology

Sophie Fillon, Konstantinos Soulis, Surender Rajasekaran et al. · The Journal of Immunology · 2006 · 89 citations

Microbial Pathogens, Innate Immune System, Immunology +20

Novel de novo pathogenic variant in the <i>ODC1</i> gene in a girl with developmental delay, alopecia, and dysmorphic features

Caleb Bupp, Chad R. Schultz, Katie Uhl et al. · American Journal of Medical Genetics Part A · 2018 · 53 citations

SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics

Ruchir Gupta, Jacob Charron, Cynthia L. Stenger et al. · Journal of Biological Chemistry · 2020 · 49 citations · Full text

High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals

Jeremy W. Prokop, Nicholas Hartog, Dave Chesla et al. · Frontiers in Immunology · 2021 · 42 citations · Full text

Covid-19 Infection, Blood Rna, Viral Persistence +12